HilleVax (NASDAQ:HLVX) Shares Up 6.2%

HilleVax, Inc. (NASDAQ:HLVXGet Rating) shares were up 6.2% during trading on Friday . The stock traded as high as $16.62 and last traded at $16.62. 4 shares were traded during trading, a decline of 100% from the average session volume of 38,379 shares. The stock had previously closed at $15.65.

HilleVax Price Performance

The company has a debt-to-equity ratio of 0.02, a current ratio of 34.77 and a quick ratio of 34.77. The business’s 50-day moving average price is $16.63 and its two-hundred day moving average price is $16.26.

HilleVax (NASDAQ:HLVXGet Rating) last released its earnings results on Thursday, November 10th. The company reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.88) by $0.43. On average, sell-side analysts anticipate that HilleVax, Inc. will post -6.93 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Strs Ohio acquired a new position in shares of HilleVax during the 2nd quarter worth $32,000. American International Group Inc. bought a new position in shares of HilleVax in the second quarter worth about $66,000. JPMorgan Chase & Co. acquired a new stake in shares of HilleVax in the 2nd quarter valued at approximately $76,000. Point72 Hong Kong Ltd bought a new stake in shares of HilleVax during the 2nd quarter valued at approximately $76,000. Finally, MetLife Investment Management LLC acquired a new position in HilleVax during the 3rd quarter worth approximately $137,000. 99.11% of the stock is currently owned by institutional investors and hedge funds.

HilleVax Company Profile

(Get Rating)

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.

Recommended Stories

Receive News & Ratings for HilleVax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HilleVax and related companies with MarketBeat.com's FREE daily email newsletter.